课题基金 / 基金详情

Retrovirus-mediated gene therapy for hepatocellular cacrinoma

Retrovirus-mediated gene therapy for hepatocellular cacrinoma
逆转录病毒介导的肝细胞癌基因治疗
批准号:
09670557
负责人:
NAKAO Kazuhiko
金额:
$2.24万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1997
资助国家:
日本
项目状态:
已结题
起止时间:
1997 至 1998

项目摘要

项目成果

NAKAO Kazuhiko的其他基金

相似基金

相关文献

中文摘要
翻译
甲胎蛋白(AFP)基因在肝细胞癌中被重新激活。我们以前曾报道过一种逆转录病毒载体(LNAFO.3TK),该载体携带由0.3kb人AFP启动子调控的单纯疱疹病毒胸苷激酶基因,在产生AFP的肝癌细胞中提供更昔洛韦(GCV)介导的细胞毒作用,与产生AFP的能力平行。用LNAFO.3TK感染高AFP产生的人肝癌细胞(HuH-7)并植入无胸腺小鼠的皮下。为提高逆转录病毒介导的基因治疗中、低AFP水平肝癌细胞的疗效,我们研制了一种新型的重组逆转录病毒载体,(LNAF0.3E +TK),其中人AFP增强子区直接连接到LNAE0.3TK的0.3kb AFP启动子。5和huH/cl.2的作用下,LNAF0.3E +TK在体外使这些细胞对GCV敏感。在PLC/PRF/5细胞的裸鼠体内模型中,GCV处理导致LNAFO.3E+TK病毒感染的细胞比LNAFO.3TK病毒感染的细胞更明显的生长抑制。因此,在LNAFO.3TK中产生这种取代以构建LNAFO.3MTK.LNAFO.3MTK感染PLQTPRF/5和huH/cl.2细胞也显示出比LNAFO.3TK感染对GCV处理更显著的敏感性。
英文摘要
The alpha-fetoprotein (AFP) gene is reactivated in hepatocellular carcinoma.. We have previously reported that a retrovirus vector (LNAFO.3TK) carrying a herpes simplex virus thymidine kinase gene regulated by the 0.3-kb human AFP promoter provides ganciclovir (GCV)-mediated cytotoxicity in AFP-producing hepatoma cells parallel with the ability of AFP production.In the present study, the in vivo effect of retrovirus-mediated gene therapy for human hepatoma cells was examined. High AFP-producing human hepatoma cells (HuH-7) was infected with LNAFO.3TK and implanted into subcutaneous of athymic mice. GCV treatment resulted in pronounced growth inhibition of the virus-infected HuH-7 xenograft in mice, but did not affect growth of parental xenograft.To improve the efficacy of retrovirus-mediated gene therapy for the intermediate and low AFP-producing hepatoma cells, new recombinant retrovirus vector (LNAFO.3E+TK) was constructed, in which human AFP enhancer region was directly linked to 0.3-kb AFP promoter of LNAEO.3TK.In the intermediate and low AFP-producing human hepatoma cells PLC/PRF/5 and huH/cl.2, respectively, LNAFO.3E+TK sensitized these cells to GCV in vitro. In vivo model using athymic mice harboring PLC/PRF/5 cells, GCV treatment resulted in more pronounced growth inhibition in the LNAFO.3E+TK virus-infected cells than in LNAFO.3TK virus-infected cells.It is reported that a G o A substitution in the human APP promoter is associated with hereditary persistence of APP, therefor this substitution was generated in LNAFO.3TK to construct LNAFO.3MTK.LNAFO.3MTK infection into PLQTPRF/5 and huH/cl.2 cells also showed more pronounced sensitivity to GCV treatment than LNAFO.3TK infection.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Hiroki Ishikawa, Keisuke Nakata, Fumihiro Mawatari, Toshihito Ueki, Shotaro Tsuruta, Akio Ido, Kazuhiko Nakao, Yuji Kato, Nobuko Ishii, Katsumi Eguchi.: "Utilization of variant-type of human alpha-fetoprotein promoter in gene therapy targeting for hepatoc
Hiroki Ishikawa、Keisuke Nakata、Fumihiro Mawatari、Toshihito Ueki、Shotaro Tsuruta、Akio Ido、Kazuhiko Nakao、Yuji Kato、Nobuko Ishii、Katsumi Eguchi。:“在针对肝细胞的基因治疗中利用人类甲胎蛋白启动子的变异型
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Toshihito Ueki: "Retrobirus-mediated gene therapy for human hepatocellular carcinoma transplanted in athymic mice" International Journal of Molecular Medicine. 1・4. 671-675 (1998)
Toshihito Ueki:“逆转录病毒介导的无胸腺小鼠肝细胞癌基因治疗”国际分子医学杂志 1・4(1998)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Toshihito Ueki: "Retrovirus-mediated gene therapy for human hepatocellular carcinoma transplanted in athymic mice" International Journal of Molecular Medicine. 1・4. 671-675 (1998)
Toshihito Ueki:“逆转录病毒介导的无胸腺小鼠肝细胞癌基因治疗”国际分子医学杂志 1・4(1998)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Basic study of anti-tumor immunity induction by CDK4 / 6 inhibitor for hepatocellular carcinoma
  • 批准号:
    18K07944
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.83万
  • 财政年份:
    2018
  • 负责人:
    NAKAO Kazuhiko
  • 依托单位:
Anti-tumor effect against hepatoma cells by suppressing the Warburg effect by AMPK activation and GSK3 inhibition
  • 批准号:
    15K09012
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $3.08万
  • 财政年份:
    2015
  • 负责人:
    NAKAO Kazuhiko
  • 依托单位:
Epithelial-mesenchymal transition and autophagy of hepatoma cells by the microenvironment change
  • 批准号:
    24590983
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $3.33万
  • 财政年份:
    2012
  • 负责人:
    NAKAO Kazuhiko
  • 依托单位:
Distinct responses of two hepatocellular carcinoma cell lines of a similar origin to immunotherapies targeting regulatory or effector T cells
  • 批准号:
    18590739
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.42万
  • 财政年份:
    2006
  • 负责人:
    NAKAO Kazuhiko
  • 依托单位:
海外基金